BAJAJ BROKING

Notification
No new Notification messages
Nisus Finance Services IPO is Open!
Apply for the Nisus Finance Services IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Suraksha Diagnostic IPO: Things Smart Investors Need to Know Before Investing

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Overview of the Company: Core Business and Market Position

Suraksha Diagnostic Ltd, established in 2005, is a provider of pathology and radiology testing services across Eastern and Northeastern India. The company operates through a network of 44 diagnostic centers and 166 sample collection points, delivering services supported by advanced digital platforms like LIMS, PACS, and AI-driven pathology. These innovations streamline operations and enhance service quality.

With a strong market position in the fragmented diagnostic sector, Suraksha Diagnostic offers integrated services combining pathology, radiology, and medical consultancy under one roof. Its customer-centric approach has ensured high retention rates, especially in the underserved regions of Bihar, Assam, and West Bengal.

For more details, visit the Suraksha Diagnostic IPO page.

Suraksha Diagnostic IPO Details and Objectives

Details

Specifications

IPO Date

November 29 – December 3, 2024

Price Band

₹420 to ₹441 per share

Total Issue Size

₹846.25 crores

Offer for Sale

1.92 crore equity shares

Face Value

₹2 per share

Listing At

NSE and BSE

Purpose of the IPO

As mentioned in the company RHP, the Company will not receive any proceeds from the Offer for sale and all such proceeds will go to the Selling Shareholders, in proportion

to the Offered Shares sold by the respective Selling Shareholder as part of the Offer.

Timeline of Suraksha Diagnostic IPO

Event

Date

IPO Open Date

November 29, 2024

IPO Close Date

December 3, 2024

Allotment Finalization

December 4, 2024

Refund Initiation

December 5, 2024

Listing Date

December 6, 2024

Pricing & Lot Size of Suraksha Diagnostic IPO

Price Band for the IPO

  • The IPO price band is set between ₹420 to ₹441 per share.

Minimum Lot Size and Application Details

  • Minimum lot size: 34 shares.
  • Minimum retail investment: ₹14,994.
  • Maximum retail investment: ₹1,94,922 for 442 shares.

How to Apply for the Suraksha Diagnostic IPO?

Online Application Process

  • Log in to your Demat account via Bajaj Broking's platform or Trading app.
  • Navigate to the IPO section and select Suraksha Diagnostic IPO.
  • Enter the number of lots and price preference (cut-off or custom bid).
  • Complete the UPI mandate for blocking the bid amount.
  • Submit your application and confirm the transaction.

Financial Health and Performance

Key Financial Metrics

  • Revenue (FY 2024): ₹222.26 Cr (up 14.75% from FY 2023).
  • PAT (FY 2024): ₹23.13 Cr (growth of 281.32% from FY 2023).
  • Net Worth: ₹187.05 Cr as of June 30, 2024.

Recent Performance and Growth Prospects

  • Significant adoption of AI-driven diagnostic tools.
  • Expansion in underserved regions, capturing market share in Eastern India.
  • Sustainable revenue growth through customized testing packages.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • Heavy reliance on East India market; limited geographical diversity.
  • High competition from established diagnostic chains.
  • Dependence on AI and digital pathology could face regulatory scrutiny.

Opportunities and Growth Potential

  • Growing preventive healthcare market.
  • Increased demand for integrated pathology and radiology services.
  • Strong digital infrastructure ensures scalability and efficiency.

Key Performance Indicators (KPI)

Metric

Value

ROE

14.09%

ROCE

21.46%

Net Debt/Equity

0.2

PAT Margin

10.57%

Suraksha Diagnostic IPO Registrar & Lead Managers

Role

Entity

Registrar

KFin Technologies Ltd.

Lead Managers

ICICI Securities, Nuvama Wealth Management, SBI Capital Markets

Company Address of Suraksha Diagnostic Ltd

  • Address: Plot No. DG-12/1, Action Area 1D, New Town, Rajarhat, Kolkata 700 156, West Bengal.
  • Email: investors@surakshanet.com
  • Contact Number: +91 33 66059750

Conclusion

Suraksha Diagnostic IPO offers investors an opportunity to participate in the growth of a leading diagnostic chain with strong market positioning and advanced digital capabilities. With its strategic expansion plans and robust technology, it promises long-term potential despite associated risks.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Suraksha Diagnostic IPO.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Frequently Asked Questions

Who is the CEO of Suraksha Diagnostic Ltd?

Answer Field

The CEO of Suraksha Diagnostic Ltd is Ms. Ritu Mittal.

When will the Suraksha Diagnostic IPO open for subscription?

Answer Field

The IPO will open for subscription on November 29, 2024.

What is the company’s core business, and how sustainable is its model?

Answer Field

Suraksha Diagnostic specializes in pathology and radiology services, supported by sustainable technology and customer-centric operations.

What is the size and growth potential of the market the company operates in?

Answer Field

The diagnostic sector is witnessing robust growth, with increasing demand for organized diagnostic services in India.

How does the company differentiate itself from competitors?

Answer Field

Its integrated diagnostics model and advanced technology platforms ensure efficiency and scalability.

What are the key risks and rewards of investing in the Suraksha Diagnostic IPO?

Answer Field

While the IPO offers opportunities in preventive healthcare, risks include geographic concentration and high competition.

Will Suraksha Diagnostic IPO pay dividends?

Answer Field

Dividend payment policies will be determined post-listing based on company profits.

No Result Found

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text